Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Sep 1;7(3):122-124.
doi: 10.6705/j.jacme.2017.0703.005.

Neuroleptic Malignant Syndrome with Minimal Dose of Amisulpride

Kishan Raj  1 , T R Jajor  2 , Ashish Khandelwal  2 , Gaurav Goyal  3
Affiliations
Case Reports

Neuroleptic Malignant Syndrome with Minimal Dose of Amisulpride

Kishan Raj et al. J Acute Med. .

Abstract

Amisulpride is an atypical antipsychotic drug, it helps in alleviation of symptoms of psychotic illnesses. Extrapyramidal features have been reported after taking amisulpride. Neuroleptic malignant syndrome (NMS) with amisulpride is rare, and have been reported earlier. In all the earlier reported cases patient received more than 150 mg of amisulpride. To the best of our knowledge we are reporting a case of NMS with very minimal dose of Amisulpride (50 mg) taken for very short period.

Keywords: amisulpride; extrapyramidal feature; neuroleptic malignant syndrome.

PubMed Disclaimer

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed). Washington, DC: American Psychiatric Association; 2000.
    1. Pelonero Anthony L., Levenson James L., Pandurangi Anand K. Neuroleptic Malignant Syndrome: A Review Psychiatric Services. 1998 Sep;49(9) doi: 10.1176/ps.49.9.1163. - DOI - PubMed
    1. Bressan Rodrigo A., Erlandsson Kjell, Jones Hugh M., Mulligan Rachel, Flanagan Robert J., Ell Peter J., Pilowsky Lyn S. Is Regionally Selective D2/D3Dopamine Occupancy Sufficient for Atypical Antipsychotic Effect? An In Vivo Quantitative [123I]Epidepride SPET Study of Amisulpride-Treated Patients American Journal of Psychiatry. 2003 Aug;160(8) doi: 10.1176/appi.ajp.160.8.1413. - DOI - PubMed
    1. Mandal Nikhiles, Sen Subrata, Singh OmP. Extrapyramidal side effects with low doses of amisulpride Indian Journal of Psychiatry. 2014;56(2) doi: 10.4103/0019-5545.130510. - DOI - PMC - PubMed
    1. Gallarda T., Olié J.-P. Neuroleptic malignant syndrome in an 72-year-old-man with Alzheimer's disease: a case report and review of the literature European Neuropsychopharmacology. 2000 Sep;10 doi: 10.1016/s0924-977x(00)80467-8. - DOI

Publication types

LinkOut - more resources